Status and phase
Conditions
Treatments
About
This is a safety and efficacy study of bimatoprost in male subjects with androgenic alopecia (AGA).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
244 participants in 7 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal